title: Influenza surveillance in Victoria, 2005.
abstract: Influenza activity remained within normal seasonal activity with a well-defined peak at week 29 (beginning 18 July) during the Victorian influenza season from May to September 2005. Surveillance was based on sentinel general practice influenza-like illness (ILI) notifications with laboratory confirmation, medical locum service ILI notifications and laboratory notification of influenza detections. One thousand and eighty-seven consultations for ILI were reported from 38 general practices, while medical practitioners from the locum service reported 317 consultations for ILI. The average weekly rate of ILI from sentinel surveillance was 7.3 per 1,000 consultations. Similar numbers of influenza A subtypes H1N1 and H3N2 were detected; 45 per cent of which were A/California/7/2004-like (H3), 44 per cent were A/New Caledonia/20/99-like (H1) and 11 per cent were A/Wellington/1/2004 (H3). Of the influenza B samples, 67 per cent were B/Hong Kong/330/2001-like and 33 per cent were B/Shanghai/361/2002-like. The influenza vaccine for 2005 contained: A/New Caledonia/20/99(H1N1)-like virus, A/Wellington/ 1/2004(H3N2)-like virus, and B/Shanghai/361/2002-like virus. Although the predominant H3 and B circulating strains were not included in the vaccine, there was reasonable serological cross protection between vaccine and circulating strains.
authors.affiliation: Epidemiology Unit, Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria.
authors.forename: Joy L
authors.initials: JL
authors.lastname: Turner
authors.forename: James E
authors.initials: JE
authors.lastname: Fielding
authors.forename: Hazel J
authors.initials: HJ
authors.lastname: Clothier
authors.forename: Heath A
authors.initials: HA
authors.lastname: Kelly
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D003140:Communicable Disease Control; D018563:Disease Notification / Q000706:statistics & numerical data; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009980:Influenza A virus / Q000145:classification / Q000276:immunology / Q000302:isolation & purification; D009981:Influenza B virus / Q000145:classification / Q000276:immunology / Q000302:isolation & purification; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control / Q000821:virology; D008297:Male; D008875:Middle Aged; D011159:Population Surveillance; D012621:Seasons; D018571:Sentinel Surveillance; D014611:Vaccination; D014739:Victoria / Q000453:epidemiology
chemical_list: D007252:Influenza Vaccines